Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation

Abstract

The positive results of this small phase III study suggest that larger and longer term trials should be conducted to assess the efficacy of systemic or intravitreal anti-TNF agent administration for primary treatment of DME.